Cargando…

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias

Acute and chronic myeloid leukemia (AML, CML) are hematologic malignancies arising from oncogene-transformed hematopoietic stem/progenitor cells known as leukemia stem cells (LSCs). LSCs are selectively resistant to various forms of therapy including irradiation or cytotoxic drugs. The introduction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schürch, Christian M., Riether, Carsten, Ochsenbein, Adrian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876024/ https://www.ncbi.nlm.nih.gov/pubmed/24427158 http://dx.doi.org/10.3389/fimmu.2013.00496

Ejemplares similares

Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ
por: Schürch, Christian, et al.
Publicado: (2013)

Interferons in hematopoiesis and leukemia
por: Schürch, Christian M, et al.
Publicado: (2013)

S126: IL-9 SECRETED BY LEUKEMIA STEM CELLS INDUCES THE EPIGENETIC ACTIVATION OF BM-INFILTRATING CD4+ T CELLS IN ACUTE MYELOID LEUKEMIA
por: Radpour, Ramin, et al.
Publicado: (2023)

Modulating CD27 signaling to treat cancer
por: Riether, Carsten, et al.
Publicado: (2012)

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia
por: Radpour, Ramin, et al.
Publicado: (2021)

P420: THE ROLE OF ACETYLCHOLINE IN THE REGULATION OF ACUTE MYELOID LEUKEMIA STEM CELLS
por: Buri, Michelle, et al.
Publicado: (2023)

CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia
por: Riether, Carsten, et al.
Publicado: (2017)

P452: CD4+ T CELLS REDUCE THE POPULATION OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Schnüriger, Noah, et al.
Publicado: (2023)

Regulation of hematopoietic and leukemia stem cells by regulatory T cells
por: Riether, Carsten
Publicado: (2022)

Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells
por: Riether, C, et al.
Publicado: (2015)

Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
por: Hinterbrandner, Magdalena, et al.
Publicado: (2021)

P802: CD70/CD27 SIGNALING PROMOTES THE EXPANSION OF CLONAL PLASMA CELL SUBSETS IN MULTIPLE MYELOMA
por: Forster, Stefan, et al.
Publicado: (2023)

Regulation of hematopoietic and leukemic stem cells by the immune system
por: Riether, C, et al.
Publicado: (2015)

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
por: Van Acker, Heleen H., et al.
Publicado: (2019)

Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)

The potential role of the thymus in immunotherapies for acute myeloid leukemia
por: Hino, Christopher, et al.
Publicado: (2023)

Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy
por: Rausch, Johanna, et al.
Publicado: (2023)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)

Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020)

Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities
por: Haas, Quentin, et al.
Publicado: (2022)

Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
por: Hargadon, Kristian M.
Publicado: (2017)

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
por: van Gulijk, Mandy, et al.
Publicado: (2018)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
por: Parisi, Sarah, et al.
Publicado: (2017)

Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
por: Gordon, John R., et al.
Publicado: (2014)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
por: Ni, Ling
Publicado: (2022)

P1343: TNIK SIGNALLING IMPAIRS SELF-RENEWAL AND LONG-TERM RECONSTITUTION CAPACITY OF HSCS
por: Palombella, Luca, et al.
Publicado: (2023)

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2021)

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2022)

The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy
por: Hardy, Marie-Pierre, et al.
Publicado: (2019)

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
por: Gardam, Bryan, et al.
Publicado: (2023)

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
por: Bossù, Paola, et al.
Publicado: (2015)

The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
por: Sánchez-León, María Luisa, et al.
Publicado: (2022)

Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease
por: Ludewig, Burkhard, et al.
Publicado: (2000)

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
por: Datta, Jashodeep, et al.
Publicado: (2015)

Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
por: da Silva, Laís Teodoro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kpc3b85avp4q7jub7gboksf6gd